Aripiprazole once-monthly 400 mg for long-term maintenance treatment of schizophrenia: a 52-week open-label study.

Peters-Strickland, Timothy; Baker, Ross A; McQuade, Robert D; Jin, Na; Eramo, Anna; Perry, Pamela; Johnson, Brian R; Duca, Anna; Sanchez, Raymond

Peters-Strickland, Timothy; Baker, Ross A; McQuade, Robert D; Jin, Na; Eramo, Anna; Perry, Pamela; Johnson, Brian R; Duca, Anna; Sanchez, Raymond.

Afiliação

Peters-Strickland T; Global Clinical Development (CNS), Otsuka Pharmaceutical Development & Commercialization, Inc. , Princeton, NJ, USA.
Baker RA; CNS Global Medical Affairs, Otsuka Pharmaceutical Development & Commercialization, Inc. , Princeton, NJ, USA.
McQuade RD; Global Medical, Regulatory Affairs and Alliances, Otsuka America Pharmaceutical Inc. , Princeton, NJ, USA.
Jin N; Biometrics, Otsuka Pharmaceutical Development & Commercialization, Inc. , Rockville, MD, USA.
Eramo A; Medical Affairs & Phase IV Clinical Affairs, Lundbeck LLC , Deerfield, IL, USA.
Perry P; Global Clinical Development (CNS), Otsuka Pharmaceutical Development & Commercialization, Inc. , Princeton, NJ, USA.
Johnson BR; Global Clinical Development (CNS), Otsuka Pharmaceutical Development & Commercialization, Inc. , Princeton, NJ, USA.
Duca A; Global Clinical Development (CNS), Otsuka Pharmaceutical Development & Commercialization, Inc. , Rockville, MD, USA.
Sanchez R; Global Clinical Development (CNS), Otsuka Pharmaceutical Development & Commercialization, Inc. , Princeton, NJ, USA.

NPJ Schizophr ; 1: 15039, 2015.

Article em En | MEDLINE | ID: mdl-27336044

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: NPJ Schizophr Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google